EXAS Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Exact Sciences Corp. Stock Analysis EXAS
United States Health Care Mid Cap EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 6,900 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Read More EXAS Chart
Exact Sciences Corp vs S&P 500 Comparative Returns
Analysis of EXAS stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Exact Sciences ... (EXA...) -5.57%
- S&P 500 -4.27%
Exact Sciences Corp Underperformed S&P 500 by 1.30%
1Y Performance
- Exact Sciences ... (EXA...) -10.79%
- S&P 500 8.86%
Exact Sciences Corp Underperformed S&P 500 by 19.65%
3Y Performance
- Exact Sciences ... (EXA...) 5.55%
- S&P 500 37.21%
Exact Sciences Corp Underperformed S&P 500 by 31.66%
5Y Performance
- Exact Sciences ... (EXA...) -35.3%
- S&P 500 92.3%
Exact Sciences Corp Underperformed S&P 500 by 127.60%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$52.91Volume
1.97MP/E Ratio (TTM)
-52 Week Range
Market Cap
8.75BAvg. Volume
2.98MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 9.36 | 10.17 | 11.72 | 13.78 | - |
EBIT per Share (TTM) | -0.91 | -4.32 | -3.25 | -1.18 | - |
Earnings per Share (EPS) (TTM) | - | -3 | - | -1 | - |
EPS Forward | - | -3.48 | -3.53 | -1.13 | - |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
George Soros
% Portfolio:
0.49 Recent Activity:31.26%
Ron Baron
% Portfolio:
0.13 Recent Activity:42.20%
Joel Greenblatt
% Portfolio:
0.08 Recent Activity:-7.57%
Cathie Wood
% Portfolio:
0.04 Recent Activity:-64.80%
Community-Curated Collections ( With EXAS )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
